Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CLDI · NYSE · Biological Products, (No Diagnostic Substances)
$0.4775−0.0275 (−5.45%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Calidi Biotherapeutics (CLDI) · oqro.io/stocks/CLDI · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Dec 12, 2025 · Filed Dec 17, 2025
Director sold ~$1.2K of CLDI shares in the open marketSourceInsider trade · Traded Aug 21, 2025 · Filed Aug 26, 2025
Director purchased ~$250K of CLDI shares in the open marketSourceInsider trade · Traded Aug 21, 2025 · Filed Aug 26, 2025
Director purchased ~$150K of CLDI shares in the open marketSourceInsider trade · Traded Aug 21, 2025 · Filed Aug 26, 2025
CEO purchased ~$50K of CLDI shares in the open marketSourceInsider trade · Traded Aug 21, 2025 · Filed Aug 26, 2025
CFO purchased ~$5K of CLDI shares in the open marketSourceInsider trade · Traded Dec 17, 2024 · Filed Dec 19, 2024
CEO sold ~$16K of CLDI shares in the open marketSource